Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Michael Kolodziej, MD
National Medical Director, Oncology Solutions, Aetna, Hartford, CT
Authored Items
Expectations of value-based cancer care
Michael Kolodziej, MD
Videos
Data to show impacts on collaborative approach to improve patient outcomes
Michael Kolodziej, MD
Videos
Payer/provider downside risk
Michael Kolodziej, MD
Videos
Payer/provider colaborations
Michael Kolodziej, MD
Videos
Are Aenta's colaboration targeting oncology providers
Michael Kolodziej, MD
Videos
Are there specific initiatives at Atena that other health plans can adopt for value based cancer care
Michael Kolodziej, MD
Videos
Last modified: January 15, 2015